Home » Topics » BioWorld Science

BioWorld Science
RSS

Biomea Fusion advances BMF-219 for leukemia

Nov. 11, 2021

BACH1 targeting has neuroprotective effects in Parkinson's disease

Nov. 11, 2021

Lennham discloses deuterated testosterone compound

Nov. 11, 2021

Gain reports preclinical data on GT-02287 and GT-02329 for Gaucher's and GBA1 Parkinson's disease

Nov. 11, 2021

Virpax announces contracts to support development and manufacturing of Envelta

Nov. 11, 2021

Zika-specific therapy found to protect fetal mouse brains

Nov. 11, 2021

Monte Rosa selects MRT-2359 as first development candidate

Nov. 11, 2021

9 Meters Biopharma and Gustave Roussy collaborate further on gut microbiome modulator NM-102

Nov. 11, 2021

Omega Therapeutics offers pipeline and research update

Nov. 11, 2021

MEF2 as key regulator and potential therapeutic target for neurodegeneration

Nov. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...